META, ELDA
 Distribuzione geografica
Continente #
EU - Europa 128
Totale 128
Nazione #
IT - Italia 128
Totale 128
Città #
Genova 85
Rapallo 23
Genoa 17
Bordighera 3
Totale 128
Nome #
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target, file e268c4ca-1e7c-a6b7-e053-3a05fe0adea1 85
The pyrazolyl-urea GeGe3 inhibits tumor angiogenesis and reveals dystrophia myotonica protein Kinase (DMPK)1 as a novel angiogenesis target, file e268c4ca-2031-a6b7-e053-3a05fe0adea1 17
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma, file e268c4cc-e362-a6b7-e053-3a05fe0adea1 8
Pyrazole and imidazo[1,2-b]pyrazole derivatives as new potential anti-tuberculosis agents., file e268c4ca-74f8-a6b7-e053-3a05fe0adea1 6
Design, synthesis and biological evaluation of new pyrazolyl-ureas and imidazopyrazolecarboxamides able to interfere with MAPK and PI3K upstream signaling involved in the angiogenesis, file e268c4c9-3bd9-a6b7-e053-3a05fe0adea1 5
New series of pyrazoles and imidazo‐pyrazoles targeting different cancer and inflammation pathways, file e268c4ce-8947-a6b7-e053-3a05fe0adea1 4
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds, file e268c4ce-3c88-a6b7-e053-3a05fe0adea1 2
Erratum: Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma (Oncotarget), file 9839634e-0091-4430-bf37-abec70cf68db 1
Totale 128
Categoria #
all - tutte 386
article - articoli 386
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 3 0 0 0 0 0 7 5 6 4 4 4
2020/202120 2 1 1 2 0 2 2 3 1 3 3 0
2021/202234 4 0 4 2 1 2 1 2 5 4 6 3
2022/202330 1 2 8 3 3 2 0 3 0 1 5 2
2023/202411 0 0 2 0 2 0 3 3 1 0 0 0
Totale 128